Organization and Nature of Operations and Basis of Presentation (Details) $ / shares in Units, $ in Thousands		12 Months Ended
	Aug. 26, 2024 shares	Dec. 31, 2025 USD ($) subsidiary $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Aug. 25, 2024 shares	Aug. 15, 2024 $ / shares	Oct. 26, 2022 shares	Oct. 25, 2022 shares
Stock-Based Compensation
Common stock, par value (in dollars per share) | $ / shares		$ 0.001	$ 0.001		$ 0.001
Reverse stock split	0.04
Common stock, shares outstanding | shares	1,005,249	35,688,350	2,782,449	25,131,230
Common stock, shares authorized | shares	14,000,000	350,000,000	350,000,000	350,000,000		350,000,000	20,000,000
Number of subsidiaries | subsidiary		9
Accumulated deficit		$ (358,710)	$ (334,971)
Cash and cash equivalents		13,056	11,609
Increase in cash		1,397	(11,574)
Net Loss		$ (23,739)	$ (25,653)
2024 Annual Meeting
Stock-Based Compensation
Common stock, shares authorized | shares		350,000,000